Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

News Release
<< Back
Taro to Announce Results for Year Ended March 31, 2017 on May 22, 2017

Earnings Call to Discuss Results to be Conducted Tuesday, May 23 at 8:00 am EDT

HAWTHORNE, N.Y.--(BUSINESS WIRE)--May 15, 2017-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the fiscal year ended March 31, 2017, on Monday, May 22, 2017.

The Company will conduct an earnings call at 8:00 am EDT on Tuesday, May 23, 2017, where senior management will discuss the Company’s performance and answer questions from participants.

The release will be accessible on Taro’s website at www.taro.com.

Earnings Call (8:00 am EDT on Tuesday, May 23, 2017)

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

Summary of events

Event   Date and time   Telephone number/ website
Earnings release   May 22, 2017 (AMC)  


Earnings conference call   8:00 am EDT

May 23, 2017


Participant Toll-Free Dial-In Number: +1 (844) 421-0601

Participant International Dial-In Number: +1 (716) 247-5800

ID: 21985230


Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call   May 23, 2017 to

June 15, 2017


+ 1 (855) 859-2056 or +1 (404) 537-3406

ID: 21985230


Via audio webcast playback, details of which will be made available on www.taro.com


About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

Source: Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer, (914) 345-9001
William J. Coote, (914) 345-9001
AVP, Business Finance, Treasurer and Investor Relations

Terms of Use
Privacy Statement
Safe Harbor Statement